|
Volume
21 Number 8
31 August 2019
|
|
Home
>
Publications
>
Current
Neuro-Oncology
>
Volume
21, Year 2019
>
Number 8, 31 August
|
|
|
|
|
|
Altieri R, Melcarne A, Soffietti R,
Rudá R, Franchino F, Pellerino A, La Rocca G, Sabatino G,
Olivi A, Ducati A, Zeppa P, Tardivo V, Mantovani C, Chiovatero I,
Martini S, Dolce P, Savastano R, Lanotte MM, Zenga F, Garbossa D.
Supratotal
Resection of Glioblastoma: Is Less More?
Surg
Technol Int. 2019 Aug 1, 2019;35:432-440∟.
PMID: 31373379∟.
Observational
study. ˍ
|
|
|
*
|
Chen JC, Lee IN, Huang C, Wu YP,
Chung CY, Lee MH, Lin MH, Yang JT.
Valproic
acid-induced amphiregulin secretion confers resistance to
temozolomide treatment in human glioma cells.
BMC
Cancer. 2019 Aug 1, 2019;19(1):756∟.
doi: 10.1186/s12885-019-5843-6∟.
PMID: 31370819∟.
Laboratory
investigation. ˍ
|
|
|
|
Pei
YC, Huang GH, Yao XH, Bian XW, Li F, Xiang Y, Yang L, Lv SQ, Liu
J.
Embryonal
tumor with multilayered rosettes, C19MC-altered (ETMR): a newly
defined pediatric brain tumor.
Int
J Clin Exp Pathol.
2019
Aug 1, 2019;12(8):3156-3163∟.
PMID:
31934159∟.
Case
report.
ˍ
|
|
|
|
Kim EH, Jo Y, Sai S, Park MJ, Kim
JY, Kim JS, Lee YJ, Cho JM, Kwak SY, Baek JH, Jeong YK, Song JY,
Yoon M, Hwang SG.
Tumor-treating
fields induce autophagy by blocking the Akt2/miR29b axis in
glioblastoma cells.
Oncogene.
2019 Aug 2, 2019;38(39):6630-6646∟.
doi: 10.1038/s41388-019-0882-7∟.
PMID: 31375748∟.
Laboratory
investigation. ˍ
|
|
|
|
Takahara K, Mochizuki Y, Ichimura S, Kurebayashi Y, Fujii K.
Brain metastasis from urachal
carcinoma.
Surg
Neurol Int. 2019 Aug 2, 2019;10:152∟.
doi: 10.25259/SNI_79_2019? PMID: 31528487∟.
Case
report. ˍ
|
|
|
|
Lahmi L, Idbaih A, Rivin Del Campo
E, Hoang-Xuan K, Mokhtari K, Sanson M, Canova CH, Carpentier A,
Jacob J, Maingon P, Feuvret L.
Whole
brain radiotherapy with concurrent temozolomide in multifocal
and/or multicentric newly diagnosed glioblastoma.
J
Clin Neurosci. 2019 Aug 6, 2019;68:39-44∟.
doi: 10.1016/j.jocn.2019.07.065∟.
PMID: 31399318∟.
Observational study. ˍ
|
|
|
|
Hainsworth JD, Becker KP, Mekhail
T, Chowdhary SA, Eakle JF, Wright D, Langdon RM, Yost KJ, Padula
GDA, West-Osterfield K, Scarberry M, Shaifer CA, Shastry M, Burris
HA 3rd, Shih K.
Phase
I/II study of bevacizumab with BKM120, an oral PI3K inhibitor, in
patients with refractory solid tumors (phase I) and
relapsed/refractory glioblastoma (phase II).
J
Neurooncol. 2019 Aug 7, 2019;144(2):303-311∟.
doi: 10.1007/s11060-019-03227-7∟.
PMID: 31392595∟.
Interventional study. ˍ
|
|
|
|
Puranik AD, Boon M, Purandare N, Rangarajan V, Gupta T, Moiyadi A,
Shetty P, Sridhar E, Agrawal A, Dev I, Shah S.
Utility
of FET-PET in detecting high-grade gliomas presenting with
equivocal MR imaging features.
World
J Nucl Med. 2019 Aug 9, 2019;18(3):266-272∟.
doi: 10.4103/wjnm.WJNM_89_18∟.
PMID: 31516370∟.
Observational study. ˍ
|
|
|
|
Vidart d'Egurbide Bagazgoïtia
N, Bailey HD, Orsi L, Guerrini-Rousseau L, Bertozzi AI,
Faure-Conter C, Leblond P, Pellier I, Freycon C, Doz F, Puget S,
Ducassou S, Lacour B, Clavel J.
Family
history of cancer and the risk of childhood brain tumors: a pooled
analysis of the ESCALE and ESTELLE studies (SFCE).
Cancer
Causes Control. 2019 Aug 9, 2019;30(10):1075-1085∟.
doi: 10.1007/s10552-019-01214-x∟.
PMID: 31399828∟.
Observational study. ˍ
|
|
|
|
La
Rocca G, Sabatino G, Altieri R, Signorelli F, Ricciardi L, Gessi
M, Della Pepa GM.
Significance
of H3K27M Mutation in "Nonmidline" High-Grade Gliomas of
Cerebral Hemispheres.
World
Neurosurg.
2019 Aug 12, 2019;131:174-176∟.
doi: 10.1016/j.wneu.2019.08.024∟.
PMID: 31415896∟.
Case report. ˍ
|
|
|
|
Michaud L, Beattie BJ, Akhurst T,
Dunphy M, Zanzonico P, Finn R, Mauguen A, Schöder H, Weber
WA, Lassman AB, Blasberg R.
18F-Fluciclovine
(18F-FACBC)
PET imaging of recurrent brain tumors.
Eur
J Nucl Med Mol Imaging. 2019 Aug 15, 2020;47(6):1353-1367∟.
doi: 10.1007/s00259-019-04433-1∟.
PMID: 31418054∟.
Observational
study. ˍ
|
|
|
|
Francis JV, Tanrıkulu B,
Danyeli AE, Özek MM.
Is
it a new culprit? "TERT promoter mutation" in an
aggressive pediatric pilocytic astrocytoma.
Childs
Nerv Syst. 2020 Aug 19, 2021 Mar;37(3):1003-1008∟.
doi: 10.1007/s00381-020-04803-3∟.
PMID: 32813054∟.
Case report. ˍ
|
|
|
|
Kong Z, Lin Y, Jiang C, Li L, Liu
Z, Wang Y, Dai C, Liu D, Qin X, Wang Y, Liu Z, Cheng X, Tian J, Ma
W.
18F-FDG-PET-based
Radiomics signature predicts MGMT promoter methylation status in
primary diffuse glioma.
Cancer
Imaging. 2019 Aug 19, 2019;19(1):58∟.
doi: 10.1186/s40644-019-0246-0∟.
PMID: 31426864∟.
Observational study. ˍ
|
|
|
|
Eoli
M, Corbetta C, Anghileri E, Di Ianni N, Milani M, Cuccarini V,
Musio S, Paterra R, Frigerio S, Nava S, Lisini D, Pessina S,
Maddaloni L, Lombardi R, Tardini M, Ferroli P, DiMeco F, Bruzzone
MG, Antozzi C, Pollo B, Finocchiaro G, Pellegatta S.
Expansion
of effector and memory T cells is associated with increased
survival in recurrent glioblastomas treated with dendritic cell
immunotherapy.
Neurooncol
Adv. 2019 Aug 20, 2019;1(1):vdz022∟.
doi: 10.1093/noajnl/vdz022∟.
PMID: 32642658∟.
Interventional
study. ˍ
|
|
|
|
Mahammedi
A, Bachir S, Escott EJ, Barnett GH, Mohammadi AM, Larvie M.
Prediction
of recurrent glioblastoma after laser interstitial thermal
therapy: The role of diffusion imaging.
Neurooncol
Adv. 2019 Aug 20, 2019;1(1):vdz021∟.
doi: 10.1093/noajnl/vdz021∟.
PMID: 32642657∟.
Observational
study. ˍ
|
|
|
|
Yerram P, Reiss SN, Modelevsky L,
Gavrilovic IT, Kaley T.
Evaluation
of toxicity of carmustine with or without bevacizumab in patients
with recurrent or progressive high grade gliomas.
J
Neurooncol. 2019 Aug 20, 2019;145(1):57-63∟.
doi: 10.1007/s11060-019-03266-0∟.
PMID: 31432377∟.
Observational
study. ˍ
|
|
|
|
Jaoude DA, Moore JA, Moore MB, Twumasi-Ankrah P, Ablah E, Moore DF
Jr.
Glioblastoma and Increased
Survival with Longer Chemotherapy Duration.
Kans
J Med. 2019 Aug 21, 2019;12(3):65-69∟.
PMID: 31489102∟.
Observational
study. ˍ
|
|
|
|
Kwon MJ, Kang SY, Cho H, Lee JI,
Kim ST, Suh YL.
Clinical
relevance of molecular subgrouping of gliomatosis cerebri per 2016
WHO classification: A clinicopathological study of 89 cases.
Brain
Pathol. 2019 Aug 21, 2020;30(2):235-245∟.
doi: 10.1111/bpa.12782∟.
PMID: 31435963∟.
Observational
study. ˍ
|
|
|
|
Jiang H, Yang K, Ren X, Cui Y, Li M, Lei Y, Lin S.
Diffuse
midline glioma with an H3 K27M mutation: A comparison integrating
the clinical, radiological, molecular features between adult and
pediatric patients.
Neuro
Oncol. 2019 Aug 24, 2020;22(5):e1-e9∟.
doi: 10.1093/neuonc/noz152∟.
PMID: 31504810∟.
Observational
study. ˍ
|
|
|
|
Lee EQ, Muzikansky A, Duda DG,
Gaffey S, Dietrich J, Nayak L, Chukwueke UN, Beroukhim R, Doherty
L, Laub CK, LaFrankie D, Fontana B, Stefanik J, Ruland S, Caruso
V, Bruno J, Ligon K, Reardon DA, Wen PY.
Phase
II trial of ponatinib in patients with bevacizumab-refractory
glioblastoma.
Cancer
Med. 2019 Aug 24, 2019;8(13):5988-5994∟.
doi: 10.1002/cam4.2505∟.
PMID: 31444999∟.
Interventional
study. ˍ
|
|
|
|
Nehama D, Di Ianni N, Musio S, Du
H, Patané M, Pollo B, Finocchiaro G, Park JJH, Dunn DE,
Edwards DS, Damrauer JS, Hudson H, Floyd SR, Ferrone S, Savoldo B,
Pellegatta S, Dotti G.
B7-H3-redirected
chimeric antigen receptor T cells target glioblastoma and
neurospheres.
EBioMedicine.
2019 Aug 26, 2019;47:33-43∟.
doi: 10.1016/j.ebiom.2019.08.030∟.
PMID: 31466914∟.
Laboratory
investigation. ˍ
|
|
|
|
Kim JH, Jang WY, Jung TY, Jung S, Kim KK, Kim HS, Kim EH, Lee MC,
Moon KS, Lee KH.
Recurrent Glioma
With Lineage Conversion From Oligodendroglioma to Astrocytoma in
Two Cases.
Front
Oncol. 2019 Aug 27, 2019;9:828∟.
doi: 10.3389/fonc.2019.00828∟.
PMID: 31508376∟.
Case
report. ˍ
|
|
|
|
Xia Y, Liao W, Huang S, Liu Z, Huang X, Yang C, Ye C, Jiang Y,
Wang J.
Nomograms for Predicting
the Overall and Cancer-Specific Survival of Patients With
High-Grade Glioma: A Surveillance, Epidemiology, and End Results
Study.
Turk
Neurosurg. 2019 Aug 27, 2020;30(1):48-59∟.
doi: 10.5137/1019-5149.JTN.26131-19.2∟.
PMID: 31452175∟.
Observational study. ˍ
|
|
|
|
Devine CA, Liu KX,
Ioakeim-Ioannidou M, Susko M, Poussaint TY, Huisman TAGM, Aboian
M, Brown D, Zaslowe-Dude C, Rao AD, Orlina LT, Rawal B, Mueller S,
Marcus KJ, Terezakis SA, Braunstein SE, Haas-Kogan DA.
Brainstem
Injury in Pediatric Patients Receiving Posterior Fossa Photon
Radiation.
Int
J Radiat Oncol Biol Phys. 2019 Aug 28, 2019;105(5):1034-1042∟.
doi: 10.1016/j.ijrobp.2019.08.039∟.
PMID: 31472183∟.
Observational study. ˍ
|
|
|
|
Stachelek
GC, Grimm J, Moore J, Huang E, Spoleti N, Redmond KJ, Lim M,
Bettegowda C, Kleinberg L.
Tumor-Treating
Field Arrays Do Not Reduce Target Volume Coverage for Glioblastoma
Radiation Therapy.
Adv
Radiat Oncol.
2019
Aug 28, 2020;5(1):62-69∟.
doi: 10.1016/j.adro.2019.08.005∟.
PMID:
32051891∟.
Laboratory
investigation.
ˍ
|
|
|
|
Bartek J Jr, Alattar AA, Dhawan S, Ma J, Koga T, Nakaji P,
Dusenbery KE, Chen CC.
Receipt of
brachytherapy is an independent predictor of survival in
glioblastoma in the Surveillance, Epidemiology, and End Results
database.
J
Neurooncol. 2019 Aug 30, 2019;145(1):75-83∟.
doi: 10.1007/s11060-019-03268-y∟.
PMID: 31471790∟.
Observational
study. ˍ
|
|
|
|
|
|
|
|
|
